ALB and familial pancreatic carcinoma: Paricalcitol and hydroxychloroquine combined with standard chemotherapy (gemcitabine and albumin-bound paclitaxel) may be more effective than paricalcitol or hydroxychloroquine alone in patients with pancreatic cancer (NCT04524702); this trial will be completed in 2024 (56).